About MiCardia

Industry Sector:

Structural Heart Disease | Implantable Devices for Heart Valve Repair

Type of Organization: Private (Venture and Private Equity Financed)

Year of Incorporation: 2004

Summary:

MiCardia has developed a new-to-world technology platform to dynamically optimize mitral valve repair, during and after surgery, to achieve the proper shape and size necessary to produce superior clinical outcomes for each patient. CE Mark for the enCorSQ™ Mitral Valve Repair System™ was received in September, 2011. The first patient to be adjusted was successfully treated in August, 2011, four months after implant.

Key Executives:

  • Jeff DuMontelle Vice President and General Manager

Investors: Please contact Jeff DuMontelle

NOT AVAILABLE FOR SALE.
MICARDIA®, MICARDIA CORPORATION®, The M Logo®, ENCORSQ™, ENCORSQ MITRAL REPAIR SYSTEM™, DYNAPLASTY™ and DYNAPLASTY SYSTEM™ are trademarks of MiCardia Corporation. The ® symbol indicates that it is registered in the U.S. The ™ symbol indicates that the mark is not registered in the U.S.